A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...

Food and Drug Administration (FDA) Commissioner Marty Makary on Monday denied recent reports suggesting plans for his agency to add a black box warning to COVID-19 vaccines. CNN reported last week ...

VIG holds only 300 stocks with a decade of consecutive annual dividend increases and charges 0.05%. DGRO requires five years of dividend growth instead of ten and yields 2% versus VIG’s 1.6%. VIGI ...

Is it three steps forward one step back for blood tests? At the 18th Clinical Trials on Alzheimer’s Disease, held December 1–4 in San Diego, new data on the FDA-approved Fujirebio Lumipulse plasma ...

Asbestos contamination in talc products is a complicated topic. Since the monumental Johnson & Johnson lawsuits over the years (which resulted in historic payouts: $4.96 billion to a group of 22 women ...

The Trump administration’s ambition to unleash biomedical innovation and sharpen America’s edge against China is colliding with a far messier reality inside the Food and Drug Administration. Investors ...

The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

The U.S. Food and Drug Administration (FDA) has proposed withdrawing a rule that would have ensured certain cosmetics were tested for asbestos. The rule was mandated under the 2022 Modernization of ...